A detailed history of Credit Suisse Ag transactions in Zoetis Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,113,496 shares of ZTS stock, worth $196 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,113,496
Previous 1,432,070 22.25%
Holding current value
$196 Million
Previous $283 Million 33.34%
% of portfolio
0.19%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $52.8 Million - $63.7 Million
-318,574 Reduced 22.25%
1,113,496 $188 Million
Q4 2023

Feb 08, 2024

SELL
$151.44 - $200.09 $4.41 Million - $5.83 Million
-29,135 Reduced 1.99%
1,432,070 $283 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $2.32 Million - $2.68 Million
13,892 Added 0.96%
1,461,205 $254 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $19.4 Million - $22.4 Million
-120,261 Reduced 7.67%
1,447,313 $249 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $28.3 Million - $34.1 Million
-194,831 Reduced 11.05%
1,567,574 $261 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $32.1 Million - $38.5 Million
244,443 Added 16.1%
1,762,405 $258 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $15.4 Million - $19 Million
-104,183 Reduced 6.42%
1,517,962 $225 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $2.74 Million - $3.52 Million
-17,591 Reduced 1.07%
1,622,145 $279 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $9.47 Million - $12.2 Million
52,230 Added 3.29%
1,639,736 $309 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $8.47 Million - $10.8 Million
43,736 Added 2.83%
1,587,506 $387 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $2.68 Million - $2.97 Million
-14,174 Reduced 0.91%
1,543,770 $300 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $214 Million - $258 Million
-1,374,346 Reduced 46.87%
1,557,944 $293 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $55.3 Million - $65 Million
383,971 Added 15.07%
2,932,290 $462 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $15.1 Million - $16.7 Million
95,901 Added 3.91%
2,548,319 $422 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $29.9 Million - $36.1 Million
218,267 Added 9.77%
2,452,418 $406 Million
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $16.5 Million - $21 Million
146,993 Added 7.04%
2,234,151 $306 Million
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $3.73 Million - $5.83 Million
40,231 Added 1.97%
2,087,158 $246 Million
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $57.5 Million - $66 Million
494,939 Added 31.89%
2,046,927 $271 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $85.2 Million - $97.2 Million
756,756 Added 95.16%
1,551,988 $193 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $3.56 Million - $4.15 Million
36,300 Added 4.78%
795,232 $90.3 Million
Q1 2019

May 14, 2019

SELL
$81.56 - $100.67 $3.61 Million - $4.46 Million
-44,312 Reduced 5.52%
758,932 $76.4 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $5.99 Million - $7.2 Million
-75,553 Reduced 8.6%
803,244 $68.7 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $1.61 Million - $1.8 Million
-19,262 Reduced 2.14%
878,797 $80.5 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $6.21 Million - $6.94 Million
-77,781 Reduced 7.97%
898,059 $76.5 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $9.07 Million - $10.7 Million
126,896 Added 14.95%
975,840 $81.5 Million
Q4 2017

Mar 14, 2018

BUY
$63.24 - $72.8 $9.05 Million - $10.4 Million
143,040 Added 20.26%
848,944 $61.2 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $15.7 Million - $18 Million
-247,772 Reduced 25.98%
705,904 $50.9 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $16.3 Million - $17.9 Million
273,559 Added 40.22%
953,676 $60.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
680,117
680,117 $42.4 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.